Pepdox
Studies
Peptides
Calculator
Reassessing retinopathy risk with tirzepatide therapy. | Pepdox
Home
/
Search
/
PMID 41051411
Reassessing retinopathy risk with tirzepatide therapy.
Diabetologia
2025
PMID: 41051411
View on PubMed
DOI: 10.1007/s00125-025-06566-5
Tirzepatide
Authors
Zhang, Na; Wang, Wenzhan; Wan, Guangming
Keywords
GIP
GLP-1 receptor agonist
Retinopathy
Tirzepatide
Type 2 diabetes